Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Auditor change
Quarterly results
Director comp.
Credit agrmnt [a]
CC transcript
Acq. announced
NATUS MEDICAL INC (BABY) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/21/2022 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "SECOND AMENDED AND RESTATED CERTIFICATE OF INCORPORATION",
"THIRD AMENDED AND RESTATED BYLAWS",
"ArchiMed completes acquisition of Natus Medical Incorporated for $1.2 billion total equity value"
07/07/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
04/18/2022 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Agreement and Plan of Merger, by and among Natus Medical Incorporated, Prince Parent Inc. and Prince Mergerco Inc",
"Retention Agreement, by and among Natus Medical Incorporated, Prince Parent Inc. and Thomas J. Sullivan",
"Natus Medical Incorporated to be acquired by ArchiMed Group for $33.50 per share in cash"
02/24/2022 8-K Quarterly results
01/10/2022 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Natus Announces Preliminary 2021 Fourth Quarter and Full Year Revenue"
12/17/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "NATUS MEDICAL INCORPORATED THOMAS J. SULLIVAN EMPLOYMENT AGREEMENT",
"Natus Medical Announces Executive Transition"
11/04/2021 8-K Quarterly results
Docs: "Natus Medical Announces Third Quarter 2021 Financial Results"
08/18/2021 8-K Quarterly results
08/05/2021 8-K Quarterly results
Docs: "Natus Medical Announces Second Quarter 2021 Financial Results"
06/28/2021 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Natus Chairperson Dr. Barbara Paul Retires&#59; Board Elects Current Board Member Joshua Levine as Chairperson"
06/17/2021 8-K Quarterly results
05/06/2021 8-K Quarterly results
02/25/2021 8-K Quarterly results
01/08/2021 8-K Quarterly results
10/29/2020 8-K Quarterly results
Docs: "Natus Medical Announces Third Quarter 2020 Financial Results"
08/11/2020 8-K Quarterly results
07/30/2020 8-K Quarterly results
06/18/2020 8-K Quarterly results
05/04/2020 8-K Quarterly results
04/30/2020 8-K Quarterly results
Docs: "Natus Medical Announces First Quarter 2020 Financial Results Q1-2020"
04/06/2020 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Natus Announces Preliminary First Quarter Revenue"
03/20/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Natus Medical Announces the Appointment of Ilan Daskal to the Board of Directors"
03/02/2020 8-K/A Quarterly results
02/06/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Natus Medical Announces Fourth Quarter and Full Year 2019 Financial Results"
01/13/2020 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Natus Reaffirms Fourth Quarter 2019 Guidance and will Present at the 38th Annual JP Morgan Healthcare Conference"
12/17/2019 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Natus Announces $50 Million Share Repurchase Program"
12/16/2019 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits  ...
Docs: "SECOND AMENDED AND RESTATED BYLAWS OF"
10/24/2019 8-K Quarterly results
Docs: "Natus Medical Announces Third Quarter 2019 Financial Results • Third quarter revenue of $123.5 million • Third quarter GAAP earnings per diluted share of $0.25 • Third quarter non-GAAP earnings per diluted share of $0.36 PLEASANTON, Calif. - Natus Medical Incorporated , a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today announced financial results for the three and nine months ended September 30, 2019. Key Results During the Quarter Ø Achieved organic revenue growth of 2% after divestitures Ø Reduced inventory by $1.6 million during the quarter Ø Reduced days sales outstanding by six days year-over-year Ø Generated $23.9 million in operating cash flow &#216..."
07/25/2019 8-K Quarterly results
Docs: "Natus Medical Announces Second Quarter 2019 Financial Results"
07/25/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Natus Medical Announces NASDAQ Ticker Symbol Change to “NTUS”"
06/07/2019 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Natus Medical Incorporated, as filed with the Delaware Secretary of State on June 5, 2019"
05/06/2019 8-K/A Quarterly results
Docs: "Update to Natus Medical First Quarter 2019 Financial Results • GAAP loss per share changed to $0.89 from $0.74 • No change to non-GAAP earnings per share"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy